Related Experiment Video
Updated: Apr 20, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
29.5K
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes
Adriano Chiò1, Marco Pagani2, Federica Agosta3
1ALS Center, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
The Lancet. Neurology
|December 3, 2014
Summary
Neuroimaging reveals amyotrophic lateral sclerosis (ALS) pathology extends beyond motor areas, affecting widespread brain regions. Further research with larger cohorts is needed to fully understand ALS pathogenesis.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Longstanding views on amyotrophic lateral sclerosis (ALS) pathophysiology are challenged by recent neuroimaging findings.
- Structural and functional neuroimaging demonstrate lesions extend beyond the motor cortex and corticospinal tracts.
Purpose of the Study:
- To review and synthesize neuroimaging findings in ALS pathophysiology.
- To highlight the extended network of brain regions affected in ALS.
- To identify limitations in current neuroimaging studies and propose future directions.
Main Methods:
- Review of structural and functional neuroimaging studies (MRI, PET) over the past two decades.
- Analysis of lesion distribution and involvement of various brain structures.
- Assessment of cellular changes like interneuron loss and gliosis.
Main Results:
- Neuroimaging reveals widespread anatomical and functional lesions in ALS, including the corpus callosum, frontal, sensory, and premotor cortices, thalamus, and midbrain.
- Early and diffuse loss of inhibitory cortical interneurons and gliosis in white-matter tracts are observed.
- ALS endophenotypes show diverse lesion patterns and varying impairments in functional and structural connectivity.
Conclusions:
- Neuroimaging has significantly advanced our understanding of ALS pathophysiology, revealing a more complex and widespread disease process.
- Positron Emission Tomography (PET) may play a role in ALS diagnosis.
- Future research requires large, well-characterized patient cohorts with standardized assessments and international collaboration to overcome current study limitations and elucidate ALS pathogenesis.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
2
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
2
Brain Imaging
1.0K
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
1.0K

